Microcarrier Stem Cell Culture to Delay Senescence

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for culturing stem cells, particularly umbilical cord blood-derived mesenchymal stem cells, are inefficient and lead to increased cell size and senescence over time.

Innovation Solution

Culturing stem cells using microcarriers, specifically polygalacturonic acid crosslinked microcarriers, maintains cell size and delays senescence by adhering cells to floating microcarriers in a cell culture solution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If stem cells are cultured using conventional plate-adherent culture methods, then cells can be maintained in culture, but cell size increases and senescence accelerates over time

Engineering Contradiction:
Improveculture durationVSAvoidcell size
Core Design Contradiction:
Duration of action of stationary objectVSShape

Solution Approach 1:

The patent introduces microcarriers as an intermediary substrate between the culture medium and stem cells. These microcarriers provide a three-dimensional surface that mimics the natural extracellular matrix, allowing cells to attach and proliferate while maintaining their original size and preventing senescence. The microcarriers act as a mediator that transforms the conventional 2D plate culture into a 3D culture system with improved cellular outcomes.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of stationary object

If stem cells are cultured using conventional plate-adherent culture methods, then cells can be maintained in culture, but senescence markers increase over time

Engineering Contradiction:
Improveculture durationVSAvoidsenescence level
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The microcarriers serve as an intermediary that fundamentally changes the culture environment. By providing a three-dimensional surface with appropriate mechanical and chemical properties, the microcarriers maintain cellular youthfulness and prevent the accumulation of senescence markers, thereby improving the reliability and therapeutic potential of cultured stem cells.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes key cultural parameters by transitioning from 2D flat surfaces to 3D microcarrier surfaces. This parameter change includes altering the surface area to volume ratio, mechanical stiffness, and topographical features, all of which collectively prevent senescence and maintain cell viability over extended culture periods.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If stem cells are cultured using microcarriers, then cell size is maintained small and senescence is delayed, but the culture system becomes more complex

Engineering Contradiction:
Improvecell efficacyVSAvoidculture system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The culture system is segmented into discrete microcarrier units that can be individually manufactured, sterilized, and controlled. Each microcarrier acts as an independent culture unit, allowing for standardized production and simplified process control despite the three-dimensional nature of the system. This segmentation makes the complex 3D culture system manageable and scalable.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20250388863A1Method for culturing stem cells using microcarrier
Publication Date: 2025.12.25 KANGSTEM BIOTECH
  • US20250388863A1 patent drawing

AI summary

The present invention relates to a method for culturing stem cells using microcarriers.